Open AccessEffects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial
Author(s) -
Paul E. Goss,
Dawn L. Hershman,
Angela M. Cheung,
James N. Ingle,
Sundeep Khosla,
Vered Stearns,
H. Chalchal,
Kendrith M. Rowland,
Hyman B. Muss,
Hannah M. Linden,
Judite Scher,
Kathleen I. Pritchard,
C Elliott,
Tanja Badovinac-Črnjević,
Jessica St. Louis,
JudithAnne W. Chapman,
Lois E. Shepherd
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/zkds-3a59
Subject(s) - anastrozole , exemestane , medicine , bone mineral , breast cancer , adjuvant , oncology , aromatase inhibitor , gynecology , aromatase , cancer , osteoporosis